
Medical Device Classification : Class B (FDA Class II)
Technology Readiness Level : TRL 4 (Animal Implantation complete)
Intended end use : Peripheral (skin) wound healing patches platform
Product description : Porous Collagen Forms
Novelty : Purified and modified form of collagen through a proprietary reconstitution process
Current Development stage/ Evaluations done :
Material characterization, molecular characterization, in vitro cell culture, rodent model demonstration
Industry Responsibility : Pre-clinical studies, Scale up, Regulatory navigation
Deliverables from Institute : Processing of raw material, process guidelines, formulation of reagents used, toolkit of forming processes. Training for industry manpower will be provided in the above deliverables
Co-development mode :
The industry and the Institute shall share responsibilities for further development. After completion of development the industry shall have the first right to refusal for Technology Transfer.